Robert Kohberger

8.0k total citations · 3 hit papers
33 papers, 6.0k citations indexed

About

Robert Kohberger is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Robert Kohberger has authored 33 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 9 papers in Microbiology and 6 papers in Infectious Diseases. Recurrent topics in Robert Kohberger's work include Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (11 papers) and Bacterial Infections and Vaccines (8 papers). Robert Kohberger is often cited by papers focused on Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (11 papers) and Bacterial Infections and Vaccines (8 papers). Robert Kohberger collaborates with scholars based in United States, United Kingdom and Finland. Robert Kohberger's co-authors include George R. Siber, Ih Chang, Keith P. Klugman, Shabir A. Madhi, Jill Hackell, Nontombi Mbelle, Nathaniel Pierce, Robin Huebner, Henry R. Shinefield and Steven Black and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

Robert Kohberger

33 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

2000 1.8k citations Steven Black, Henry R. Shinefield et al. The Pediatric Infectious Disease Journal profile →
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

2001 1.2k citations Helena Käyhty, Robert Kohberger et al. New England Journal of Medicine profile →
A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection

2003 767 citations Keith P. Klugman, Shabir A. Madhi et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Kohberger United States	22	4.9k	2.6k	511	458	394	33	6.0k
David Jenkins United Kingdom	51	6.6k 1.3×	732 0.3×	460 0.9×	363 0.8×	518 1.3×	243	11.3k
Brian Greenwood United Kingdom	43	4.2k 0.9×	3.7k 1.4×	921 1.8×	1.4k 3.1×	307 0.8×	132	7.3k
Daron G. Ferris United States	36	5.5k 1.1×	936 0.4×	240 0.5×	271 0.6×	103 0.3×	136	7.1k
Marc Arbyn Belgium	57	12.0k 2.4×	1.6k 0.6×	433 0.8×	637 1.4×	423 1.1×	165	14.9k
Shelley L. Deeks Canada	33	2.6k 0.5×	750 0.3×	869 1.7×	247 0.5×	109 0.3×	158	3.9k
Kari Auranen Finland	28	2.4k 0.5×	702 0.3×	720 1.4×	447 1.0×	152 0.4×	99	3.8k
Thomas M. Lietman United States	51	2.7k 0.5×	2.0k 0.8×	1.4k 2.7×	2.3k 5.1×	431 1.1×	389	10.8k
Michael Marks United Kingdom	35	2.3k 0.5×	584 0.2×	1.4k 2.7×	738 1.6×	1.2k 3.0×	230	6.2k
William C. Blackwelder United States	48	2.9k 0.6×	1.2k 0.4×	1.7k 3.4×	728 1.6×	682 1.7×	125	8.8k
Roberto Gasparini Italy	35	2.5k 0.5×	423 0.2×	936 1.8×	294 0.6×	121 0.3×	169	4.1k

Countries citing papers authored by Robert Kohberger

Since Specialization

Citations

This map shows the geographic impact of Robert Kohberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Kohberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Kohberger more than expected).

Fields of papers citing papers by Robert Kohberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Kohberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Kohberger. The network helps show where Robert Kohberger may publish in the future.

Co-authorship network of co-authors of Robert Kohberger

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Kohberger. A scholar is included among the top collaborators of Robert Kohberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Kohberger. Robert Kohberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Treanor, John J., Brandon Essink, Steven Hull, et al.. (2013). Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant. Vaccine. 31(48). 5760–5765. 73 indexed citations

Sinha, Anushua, Soyeon Kim, Gary Ginsberg, et al.. (2012). Economic burden of acute lower respiratory tract infection in South African children. Paediatrics and International Child Health. 32(2). 65–73. 15 indexed citations

Treanor, John J., Hana M. El Sahly, James C. King, et al.. (2011). Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial. Vaccine. 29(44). 7733–7739. 129 indexed citations

Williamson, E. Diane, et al.. (2010). Predictive models and correlates of protection for testing biodefence vaccines. Expert Review of Vaccines. 9(5). 527–537. 20 indexed citations

Saaka, Mahama, Brown J. Okoko, Robert Kohberger, et al.. (2008). Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia. Vaccine. 26(29-30). 3719–3726. 44 indexed citations

Kohberger, Robert, David K. Jemiolo, & Fernando Noriega. (2008). Prediction of pertussis vaccine efficacy using a correlates of protection model. Vaccine. 26(27-28). 3516–3521. 24 indexed citations

O’Brien, Katherine L., Jennifer C. Moïsi, Lawrence H. Moulton, et al.. (2007). Predictors of Pneumococcal Conjugate Vaccine Immunogenicity among Infants and Toddlers in an American Indian PnCRM7 Efficacy Trial. The Journal of Infectious Diseases. 196(1). 104–114. 30 indexed citations

Vesikari, Timo, Aino Karvonen, Shang‐Qin Zeng, et al.. (2006). Safety, Efficacy, and Immunogenicity of 2 Doses of Bovine‐Human (UK) and Rhesus–Rhesus‐Human Rotavirus Reassortant Tetravalent Vaccines in Finnish Children. The Journal of Infectious Diseases. 194(3). 370–376. 51 indexed citations

Dagan, Ron, Noga Givon‐Lavi, Drora Fraser, et al.. (2005). Serum Serotype‐Specific Pneumococcal Anticapsular Immunoglobulin G Concentrations after Immunization with a 9‐Valent Conjugate Pneumococcal Vaccine Correlate with Nasopharyngeal Acquisition of Pneumococcus. The Journal of Infectious Diseases. 192(3). 367–376. 123 indexed citations

10.

Kong, Lan, Robert Kohberger, & Gary G. Koch. (2004). Type I Error and Power in Noninferiority/Equivalence Trials with Correlated Multiple Endpoints: An Example from Vaccine Development Trials. Journal of Biopharmaceutical Statistics. 14(4). 893–907. 13 indexed citations

11.

O’Brien, Katherine L., Lawrence H. Moulton, Raymond Reid, et al.. (2003). Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. The Lancet. 362(9381). 355–361. 299 indexed citations

12.

Klugman, Keith P., Shabir A. Madhi, Robin Huebner, et al.. (2003). A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection. New England Journal of Medicine. 349(14). 1341–1348. 767 indexed citations breakdown →

13.

Jódar, Luis, Jay C. Butler, George M. Carlone, et al.. (2003). Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine. 21(23). 3265–3272. 298 indexed citations

14.

Moulton, Lawrence H., Katherine L. O’Brien, Robert Kohberger, et al.. (2001). Design of a Group-Randomized Streptococcus pneumoniae Vaccine Trial. Controlled Clinical Trials. 22(4). 438–452. 48 indexed citations

15.

Black, Steven, Jill Hackell, George R. Siber, et al.. (2000). Efficacy, Safety, and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Children. The American Journal of Managed Care. 6. 3 indexed citations

16.

Black, Steven, Henry R. Shinefield, Bruce Fireman, et al.. (2000). Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. The Pediatric Infectious Disease Journal. 19(3). 187–195. 1817 indexed citations breakdown →

17.

Shinefield, Henry R., Steven Black, Paula Ray, et al.. (1999). Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. The Pediatric Infectious Disease Journal. 18(9). 757–763. 234 indexed citations

18.

Kohberger, Robert & Barry J. Everitt. (1994). Cluster Analysis. Technometrics. 36(2). 216–216. 1 indexed citations

19.

Kohberger, Robert. (1980). Statistical evaluation of the direct linear plot method for estimation of enzyme kinetic parameters. Analytical Biochemistry. 101(1). 1–6. 8 indexed citations

20.

Kohberger, Robert, et al.. (1979). Hypnotic treatment of smoking: the single-treatment method revisited. American Journal of Psychiatry. 136(1). 83–85. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact